| Mean platelet volume: a useful marker of inflammatory bowel disease activity AN Kapsoritakis, MI Koukourakis, A Sfiridaki, SP Potamianos, ... Official journal of the American College of Gastroenterology| ACG 96 (3 …, 2001 | 570 | 2001 |
| Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease K Karmiris, A Avgerinos, A Tavernaraki, C Zeglinas, P Karatzas, ... Journal of Crohn's and Colitis 10 (4), 429-436, 2016 | 174 | 2016 |
| An epidemiological study of acute upper gastrointestinal bleeding in Crete, Greece GA Paspatis, E Matrella, A Kapsoritakis, C Leontithis, N Papanikolaou, ... European journal of gastroenterology & hepatology 12 (11), 1215-1220, 2000 | 154 | 2000 |
| Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity KA Oikonomou, AN Kapsoritakis, C Theodoridou, D Karangelis, ... Journal of gastroenterology 47, 519-530, 2012 | 145 | 2012 |
| Renal manifestations and complications of inflammatory bowel disease K Oikonomou, A Kapsoritakis, T Eleftheriadis, I Stefanidis, S Potamianos Inflammatory bowel diseases 17 (4), 1034-1045, 2011 | 134 | 2011 |
| Laparoendoscopic rendezvous versus preoperative ERCP and laparoscopic cholecystectomy for the management of cholecysto-choledocholithiasis: interim analysis of a controlled … G Tzovaras, I Baloyiannis, E Zachari, D Symeonidis, D Zacharoulis, ... Annals of surgery 255 (3), 435-439, 2012 | 128 | 2012 |
| Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease AC Manolakis, AN Kapsoritakis, EK Tiaka, SP Potamianos Digestive diseases and sciences 56, 1601-1611, 2011 | 117 | 2011 |
| Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease IE Koutroubakis, A Sfiridaki, IA Mouzas, A Maladaki, A Kapsoritakis, ... Official journal of the American College of Gastroenterology| ACG 95 (1 …, 2000 | 113 | 2000 |
| Appendectomy, tonsillectomy, and risk of inflammatory bowel disease: case-controlled study in Crete IE Koutroubakis, IG Vlachonikolis, A Kapsoritakis, S Spanoudakis, ... Diseases of the colon & rectum 42, 225-230, 1999 | 96 | 1999 |
| A Review of the Postulated Mechanisms Concerning the Association of Helicobacter pylori with Ischemic Heart Disease A Manolakis, AN Kapsoritakis, SP Potamianos Helicobacter 12 (4), 287-297, 2007 | 91 | 2007 |
| Vascular endothelial growth factor in inflammatory bowel disease A Kapsoritakis, A Sfiridaki, E Maltezos, K Simopoulos, A Giatromanolaki, ... International journal of colorectal disease 18, 418-422, 2003 | 86 | 2003 |
| Impact of laparoscopic sleeve gastrectomy on gastrointestinal motility E Sioka, G Tzovaras, K Perivoliotis, V Bakalis, E Zachari, D Magouliotis, ... Gastroenterology Research and Practice 2018 (1), 4135813, 2018 | 77 | 2018 |
| Angiogenin, angiopoietin-1, angiopoietin-2, and endostatin serum levels in inflammatory bowel disease KA Oikonomou, AN Kapsoritakis, AI Kapsoritaki, AC Manolakis, EK Tiaka, ... Inflammatory bowel diseases 17 (4), 963-970, 2011 | 67 | 2011 |
| Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome AC Manolakis, AN Kapsoritakis, P Georgoulias, C Tzavara, V Valotassiou, ... BMC gastroenterology 10, 1-7, 2010 | 67 | 2010 |
| Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer. A Giatromanolaki, MI Koukourakis, GP Stathopoulos, A Kapsoritakis, ... Oncology research 12 (1), 33-41, 2000 | 66 | 2000 |
| TLR4 gene polymorphisms: evidence for protection against type 2 diabetes but not for diabetes-associated ischaemic heart disease AC Manolakis, AN Kapsoritakis, EK Tiaka, A Sidiropoulos, A Gerovassili, ... European journal of endocrinology 165 (2), 261-267, 2011 | 64 | 2011 |
| Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases AE Germenis, EE Yiannaki, K Zachou, V Roka, S Barbanis, C Liaskos, ... Clinical and Vaccine Immunology 12 (8), 941-948, 2005 | 58 | 2005 |
| Imbalance of tissue inhibitors of metalloproteinases (TIMP)–1 and–4 serum levels, in patients with inflammatory bowel disease AN Kapsoritakis, AI Kapsoritaki, IP Davidi, VD Lotis, AC Manolakis, ... BMC gastroenterology 8, 1-8, 2008 | 57 | 2008 |
| Drug-induced nephrotoxicity in inflammatory bowel disease KA Oikonomou, AN Kapsoritakis, I Stefanidis, SP Potamianos Nephron Clinical Practice 119 (2), c89-c96, 2011 | 53 | 2011 |
| Resistance to activated protein C, factor V leiden and the prothrombin G20210A variant in patients with colorectal cancer GA Paspatis, A Sfyridaki, N Papanikolaou, K Triantafyllou, A Livadiotaki, ... Pathophysiology of haemostasis and thrombosis 32 (1), 2-7, 2002 | 52 | 2002 |
